ARTICLES

nox medical model firm award
Sleep Disorders

Nox Medical Recognized as a Model Firm

Nox Medical has been recognized as a Model Firm for the Company of the Year 2021 awards in Iceland, a recognition that is assigned to companies that are considered to excel in creating a good working environment. Nox Medical is one of 15 companies in the category of mid-sized companies that are […]

cadwell ensodata
Partnerships

Cadwell Partners with EnsoData for Sleep AI

Cadwell Industries, Inc announces a partnership with EnsoData, a healthcare artificial intelligence (AI) company dedicated to improving the lives of medical professionals and their patients. Cadwell is the first sleep diagnostic equipment provider to more deeply integrate EnsoData’s EnsoSleep AI scoring solution by modifying its Easy III PSG software platform. This […]

sovasage logo on background
Digital Health

sovaSage Updates TherapistAssist with Instantaneous Handoff of Mask Recommendations

sovaSage Incorporated, announced the latest release of its TherapistAssist software (version 7.0). This new release provides an effortless and instantaneous handoff of mask and mask sizing recommendations between sleep labs, home sleep study services and durable medical equipment (DME) providers. The patent-pending software, already delivering efficiency and accuracy benefits to […]

uva
Research & Studies

Antibiotics Don’t Help Deadly Lung-Scarring Disease

Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death. While there were no statistical benefits for patients with the lung-scarring disease, the new research will prevent unnecessary […]

Noctrix health restless legs syndrome
Research & Studies

Noctrix Health Enrolls First Patient in RLS Wearable Device Trial

Noctrix Health, Inc. announced that the first patient has been enrolled in a multi-center, randomized controlled clinical trial. The RESTFUL Study (ClinicalTrials.gov Identifier: NCT04874155) is a first of its kind two-phase, randomized, double-blind, sham-controlled clinical trial to evaluate the Company’s proprietary wearable NTX100 Neuromodulation System in patients with moderate-severe primary RLS […]